# Baylor University Medical Center

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/baylor-university-medical-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 77.6 |
| Citations | 1,333,539 |
| City | Dallas |
| Country | US |
| Description | Baylor University Medical Center is a research organisation in Dallas, US. OpenAlex records 14,397 works and 1,333,539 citations for it. 3,262 researchers list it as their most recent affiliation. |
| Homepage | http://www.baylorhealth.com/PhysiciansLocations/Dallas/Pages/Default.aspx |
| OpenAlex ID | https://openalex.org/I2802366037 |
| Researchers | 3,262 |
| ROR ID | https://ror.org/03nxfhe13 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q4874615 |
| Works | 14,397 |

## University papers

Showing 12 of 162.

- [2013 ACCF/AHA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2013-accf-aha-guideline-for-the-management-of-heart-failure/)
- [Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-versus-enalapril-in-heart-failure/)
- [Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction](https://scholariq.org/papers/effect-of-captopril-on-mortality-and-morbidity-in-patients-with-left-ventricular/)
- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure](https://scholariq.org/papers/the-effect-of-carvedilol-on-morbidity-and-mortality-in-patients-with-chronic/)
- [Cardiac Resynchronization in Chronic Heart Failure](https://scholariq.org/papers/cardiac-resynchronization-in-chronic-heart-failure/)
- [2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2017-acc-aha-hfsa-focused-update-of-the-2013-accf-aha-guideline-for-the-2/)
- [2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary](https://scholariq.org/papers/2013-accf-aha-guideline-for-the-management-of-heart-failure-executive-summary/)
- [Forecasting the Future of Cardiovascular Disease in the United States](https://scholariq.org/papers/forecasting-the-future-of-cardiovascular-disease-in-the-united-states/)
- [2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America](https://scholariq.org/papers/2017-acc-aha-hfsa-focused-update-of-the-2013-accf-aha-guideline-for-the-3/)
- [Effect of Carvedilol on Survival in Severe Chronic Heart Failure](https://scholariq.org/papers/effect-of-carvedilol-on-survival-in-severe-chronic-heart-failure-2/)

## University researchers

- [Javed Butler](https://scholariq.org/researchers/javed-butler/)
- [Milton Packer](https://scholariq.org/researchers/milton-packer/)
- [Stuart J. Spechler](https://scholariq.org/researchers/stuart-j-spechler/)
- [Subhash Banerjee](https://scholariq.org/researchers/subhash-banerjee/)
- [Dan M. Meyer](https://scholariq.org/researchers/dan-m-meyer/)
- [Babak Namazi](https://scholariq.org/researchers/babak-namazi/)

## University top topics

Showing 8 of 25.

- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Transplantation: Methods and Outcomes](https://scholariq.org/topics/transplantation-methods-and-outcomes/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.